Smart fusion: high affinity peptide capture reagents

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201500030C
Awardee
Awarding agency
Obligated
$999,685

Award facts

Opportunity
  • N44CO5102275 Solicitation number
Contract value 100% obligated
$999,685.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition after exclusion of sources · 5 offers Alternative Sources
Pricing
Cost Plus Fixed Fee
Place of performance
Columbia, MD 21045, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00002 -$315
Other Administrative Action 1 · Other function: smart fusion: high affinity peptide capture reagents $0
Original award $1,000,000

About this award

The National Cancer Institute awarded a $999,685 definitive contract to A&G Pharmaceutical, Inc. for smart fusion high affinity peptide capture reagents on September 22, 2015, under cost plus fixed fee pricing with no set-aside.

Place of performance is Columbia, MD. The contract ceiling value is $999,685 with an ultimate completion date of March 31, 2018.

Quick answers

Who was awarded contract HHSN261201500030C?

HHSN261201500030C was awarded to A&G Pharmaceutical, Inc. by National Cancer Institute (National Institutes of Health) on September 22, 2015.

How much is contract HHSN261201500030C worth?

The government has obligated $999,685 on HHSN261201500030C.

Was contract HHSN261201500030C competed?

The extent of competition for HHSN261201500030C was full and open competition after exclusion of sources. The government received 5 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award